Polymyxin Impurity 1 is a lipopeptide-related species arising from altered acylation or peptide-cyclization pathways. Its structural differences affect hydrophobicity and ion-binding properties. Researchers analyze it for comprehensive impurity fingerprinting. Applications include QC refinement, lipopeptide degradation studies, and structural variant comparison.
CAT No: R2836
CAS No:343979-23-7
Synonyms/Alias:N-((S)-4-amino-1-(((2S,3R)-1-(((S)-4-amino-1-oxo-1-(((3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-((R)-1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl)amino)butan-2-yl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-1-oxobutan-2-yl)-3-hydroxy-6-methyloctanamide
Polymyxin Impurity 1 is a structurally related analogue of polymyxin antibiotics, often encountered as a byproduct or degradation product during the synthesis and storage of polymyxin compounds. Characterized by its unique peptide sequence and subtle variations in its molecular structure, Polymyxin Impurity 1 provides researchers with a valuable reference standard for analytical and quality control purposes. Its presence in pharmaceutical preparations necessitates precise identification and quantification, making it an essential tool for laboratories focused on antibiotic development and safety assessment. The compound's stability and distinct chromatographic profile enable reliable differentiation from the parent polymyxin molecules, supporting advanced studies in pharmaceutical chemistry, degradation pathways, and impurity profiling.
Pharmaceutical Analysis: In pharmaceutical analysis, Polymyxin Impurity 1 is widely utilized as a reference standard for the development and validation of analytical methods such as HPLC and LC-MS. Its inclusion in impurity profiling protocols allows researchers to accurately quantify and monitor trace levels of impurities in polymyxin formulations, ensuring the consistency and safety of pharmaceutical products. By serving as a benchmark for method calibration, it aids in the detection of deviations during manufacturing or storage, thus supporting stringent quality control practices in antibiotic production facilities.
Degradation Pathway Studies: The application of Polymyxin Impurity 1 in degradation pathway studies is critical for understanding the stability and breakdown mechanisms of polymyxin antibiotics. Researchers employ this impurity to simulate and investigate the chemical and environmental factors that contribute to the degradation of the parent drug. Through controlled experiments, it becomes possible to elucidate the kinetics and byproduct spectrum associated with polymyxin decomposition, informing the design of more stable formulations and improved storage conditions.
Process Development and Optimization: During the synthesis and purification of polymyxin antibiotics, the presence of Polymyxin Impurity 1 provides valuable insight into process efficiency and selectivity. By monitoring the formation and removal of this impurity, process chemists can optimize reaction conditions, purification steps, and overall yields. The ability to track and minimize impurity levels directly impacts the scalability and economic viability of manufacturing processes, contributing to the production of high-quality active pharmaceutical ingredients.
Analytical Instrument Calibration: Laboratories engaged in routine analysis of polymyxin compounds frequently rely on Polymyxin Impurity 1 for instrument calibration and performance verification. Its well-characterized properties make it an ideal calibrant for chromatographic and spectrometric systems, ensuring accurate retention time assignment and peak identification. Regular use in calibration protocols helps maintain data integrity and reproducibility, which are critical for regulatory submissions and batch release testing.
Reference Material for Research and Development: In research and development settings, Polymyxin Impurity 1 serves as a reference material for the investigation of structure-activity relationships, impurity toxicity, and antibiotic resistance mechanisms. By providing a representative model of non-parental species found in polymyxin preparations, it enables scientists to assess the impact of impurities on biological activity and therapeutic index. Such studies contribute to a deeper understanding of the molecular diversity within polymyxin antibiotics and support innovation in the field of antimicrobial drug design.
Polymyxin Impurity 1 continues to play a pivotal role in the advancement of pharmaceutical sciences, particularly in the context of antibiotic quality control, process optimization, and analytical method development. Its multifaceted applications extend from routine laboratory analysis to fundamental research, where it supports the identification, quantification, and characterization of impurities in complex drug matrices. By enabling precise monitoring and control of impurity profiles, it helps safeguard product quality and informs best practices in antibiotic manufacturing. As a result, Polymyxin Impurity 1 remains an indispensable resource for scientists seeking to enhance the safety, efficacy, and reliability of polymyxin-based therapeutics.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More